MedTrace Logo

The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing

NCT04767958 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2022-05-02

No results posted yet for this study

Summary

This study is being conducted to study the use and application of a point-of-care (POC) Covid-19 test developed by Spartan BioSciences and recently approved for clinical use by Health Canada.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Spartan COVID-19 Platform

Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2021-05-31
Completion
2021-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04767958 on ClinicalTrials.gov